Israel-based aesthetic device company Syneron Medical has introduced a new picosecond device, PicoWay.

With 532nm and 1064nm wavelengths, the dual wavelength device uses PicoWay technology to generate picosecond pulses to treat pigmented lesions and tattoos, including recalcitrant tattoos.

Syneron Medical CEO Amit Meridor said the company has introduced the most advanced picosecond laser system, following years of investment in PicoWay’s research and development.

"Its advanced technology demonstrates, once again, Syneron’s commitment to developing innovative aesthetic devices that enable physicians to provide best-in-practice treatments for their patients," Meridor added.

PicoWay integrates highest peak power and the shortest pulse durations of any aesthetic laser, and creates strongest photo-mechanical impact, which allows in the safe fracturing of tattoo ink or pigmentation.

PicoWay received CE mark approval, and is expected to obtain US FDA approval by the end of this year, which is currently under pending.

Syneron said that the staged launch of PicoWay commences in the international market during October and will continue in the first half of 2015.